Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · IEX Real-Time Price · USD
1.360
-0.040 (-2.86%)
At close: May 1, 2024, 3:57 PM
1.300
-0.060 (-4.41%)
After-hours: May 1, 2024, 4:06 PM EDT
Aethlon Medical Revenue
Aethlon Medical had revenue of $574.25K in the twelve months ending December 31, 2023, with 4,278.20% growth year-over-year. In the fiscal year ending March 31, 2023, Aethlon Medical had annual revenue of $574.25K with 95.21% growth.
Revenue (ttm)
$574.25K
Revenue Growth
+4,278.20%
P/S Ratio
6.02
Revenue / Employee
$38,283
Employees
15
Market Cap
3.46M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
Mar 31, 2019 | 229.63K | 80.00K | 53.47% |
Mar 31, 2018 | 149.63K | -242.45K | -61.84% |
Mar 31, 2017 | 392.07K | -494.50K | -55.78% |
Mar 31, 2016 | 886.57K | 124.16K | 16.28% |
Mar 31, 2015 | 762.42K | -861.35K | -53.05% |
Mar 31, 2014 | 1.62M | 393.77K | 32.01% |
Mar 31, 2013 | 1.23M | -129.62K | -9.53% |
Mar 31, 2012 | 1.36M | - | - |
Mar 31, 2011 | 0 | - | - |
Mar 31, 2010 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Applied DNA Sciences | 9.00M |
ReShape Lifesciences | 8.68M |
Evoke Pharma | 5.18M |
Helius Medical Technologies | 644.00K |
Finch Therapeutics Group | 107.00K |
AEMD News
- 2 months ago - Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices - PRNewsWire
- 2 months ago - Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 - PRNewsWire
- 6 months ago - Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. - PRNewsWire
- 6 months ago - Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 - PRNewsWire
- 7 months ago - Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology - PRNewsWire
- 7 months ago - Aethlon Announces Reverse Stock Split - PRNewsWire